Evidence map›Paper›PMID 40972476›Full record

ArticleMolecular pharmacology2025

Differential RELA and GR recruitment to the BIRC3/BIRC2 locus: Molecular insight as to combinatorial regulation by proinflammatory cytokines and glucocorticoid.

Andrew J Thorne, Alex Gao, Amandah Necker-Brown, Akanksha Bansal, Keerthana Kalyanaraman, Priyanka Chandramohan, Sarah K Sasse, Anthony N Gerber, Mahmoud M Mostafa, Robert Newton

Abstract read
In one paragraph

Article in Molecular pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrew J ThorneDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Alex GaoDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Amandah Necker-BrownDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Akanksha BansalDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Keerthana KalyanaramanDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Priyanka ChandramohanDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Sarah K SasseDepartment of Medicine, National Jewish Health, Denver, Colorado.
Anthony N GerberDepartment of Medicine, National Jewish Health, Denver, Colorado; Department of Immunology and Genomic Medicine, National Jewish Health, Denver, Colorado; Department of Medicine, University of Colorado, Aurora, Colorado.
Mahmoud M MostafaDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Robert NewtonDepartment of Physiology & Pharmacology and Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: rnewton@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In pulmonary epithelial cells, baculoviral inhibitor of apoptosis repeat-containing (BIRC) gene, BIRC3, and to a lesser extent, BIRC2, mRNAs were upregulated by interleukin (IL)-1β and tumor necrosis factor-α. Glucocorticoids also induced BIRC3 mRNA and the glucocorticoid receptor (GR) was recruited to GR-binding regions (GBRs) proximal to, and within, BIRC3 in A549 and BEAS-2B cells. Four such GBRs drove glucocorticoid-inducible, Organon 34517-antagonized, transcription in A549 cells. IL-1β and tumor necrosis factor-α recruited the nuclear factor (NF)-κB transactivating subunit, v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA), to RELA-binding regions (RBRs) (R4 and R7) upstream of the BIRC3 and BIRC2 transcription start sites. These RBRs drove IL-1β-inducible transcription that involved NF-κB. Thus, direct regulation of BIRC3 by GR and BIRC3/BIRC2 by NF-κB is indicated. IL-1β-plus-budesonide also recruited RELA to multiple GBRs, whereas GR was recruited to the main IL-1β-induced RBR (R4), effects that correlated with positive IL-1β/glucocorticoid transcriptional cooperativity or additivity. At the R5 GBR, RELA was not recruited and both GR binding and glucocorticoid-dependent transcription reduced (infra-additivity) on cotreatment. Similarly, the R7 RBR barely recruited GR and IL-1β-induced transcription showed infra-additivity with IL-1β-plus-glucocorticoid. R8 recruited GR and RELA primarily with IL-1β-plus-glucocorticoid and revealed transcriptional synergy. Thus, GR/RELA-corecruitment yielded positive cooperative and additive transcriptional effects, whereas recruiting one factor alone associated with infra-additivity. Furthermore, DNA looping revealed how multiple RBRs/GBRs may integrate to control transcription. Because IL-1β- and glucocorticoid-dependent coupregulation of apoptotic/antiapoptotic genes was widespread, the combinatorial recruitment of RELA/GR to regulatory genes, including BIRC3, CFLAR plus others in the NF-κB pathway, may be critical to cell fate determination in inflammation. SIGNIFICANCE STATEMENT: Identification of functional GR- and RELA-binding regions at the BIRC3/BIRC2 locus explains the upregulation of BIRC3 expression by glucocorticoids and inflammatory cytokines. Cytokine-plus-glucocorticoid cotreatment revealed positive cooperative and additive interactions between GR and RELA, whereas DNA regions binding only one factor showed reduced effects on binding and transcription. These region-specific outcomes, combined with DNA looping between regulatory regions, provides insight as to how factors at multiple DNA regions may integrate their outputs to produce combinatorial regulation of apoptotic/antiapoptotic genes.

Indexed as

Baculoviral IAP Repeat-Containing 3 ProteinCytokinesGlucocorticoidsInhibitor of Apoptosis ProteinsReceptors, GlucocorticoidTranscription Factor RelAA549 CellsHumansInterleukin-1betaNF-kappa BUbiquitin-Protein LigasesBaculoviral IAP Repeat-Containing 3 ProteinBIRC2 protein, humanBIRC3 protein, humanCytokinesGlucocorticoidsInhibitor of Apoptosis ProteinsInterleukin-1betaNF-kappa BReceptors, GlucocorticoidRELA protein, humanTranscription Factor RelAUbiquitin-Protein LigasesBaculoviral inhibitor of apoptosis repeat–containing geneCytokinesGlucocorticoid receptorNuclear factor-κBTranscriptional control

Identifiers

PMID40972476
PMCPMC12799407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.